ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.090,32
-0,65%
S&P 500
5.795,34
-0,54%
Dow Jones
42.071,96
0,32%
Euro vs US Dollar
1,02054
-0,38%
Bitcoin
91.917,98
-2,73%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Tango Therapeutics Inc (TNGX) Börsenkurse

Tango Therapeutics Inc

Tango Therapeutics Inc (TNGX)

NASDAQ
2,805
-0,12
( -4,10% )
Aktualisiert: 15:39:20
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
2,805
Gebot
2,80
Fragen
2,81
Volumen
18.915
2,80 Tagesbereich 2,975
2,70 52-Wochen-Bereich 13,005
Marktkapitalisierung
301,307M
Handelsende
2,925
Handelsbeginn
2,97
Letzte Trade
100
@
2.805
Letzter Handelszeitpunkt
15:39:20
Finanzvolumen
US$ 54.824
VWAP
2,8984
Durchschnittliches Volumen (3 Mio.)
2.042.554
Ausgegebene Aktien
107.417.818
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,04
Gewinn pro Aktie (EPS)
-0,95
Erlöse
36,53M
Nettogewinn
-101,74M

Über Tango Therapeutics Inc

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.tangotx.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Tango Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TNGX. The last closing price for Tango Therapeutics was US$2,93. Over the last year, Tango Therapeutics shares have traded in a share price range of US$ 2,70 to US$ 13,005.

Tango Therapeutics currently has 107.417.818 shares in issue. The market capitalisation of Tango Therapeutics is US$314,20 million. Tango Therapeutics has a price to earnings ratio (PE ratio) of -3.04.

TNGX Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report

2 Stunden vor
Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

02 Januar 2025
Edgar (US Regulatory)

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

03 Dezember 2024
Business Wire

Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

27 November 2024
Business Wire

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

20 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

19 November 2024
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

08 November 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

07 November 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

06 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

06 November 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.37-11.65354330713.1753.652.7613905763.32168037CS
4-0.205-6.810631229243.013.652.71513305233.08459166CS
12-4.655-62.3994638077.467.462.720425543.68972218CS
26-7.165-71.86559679049.9712.0152.714249795.57266761CS
52-7.945-73.906976744210.7513.0052.710504226.73188016CS
156-5.815-67.45939675178.6213.032.477307357.05522254CS
260-6.805-70.81165452659.6118.842.476633197.28620761CS

TNGX - Frequently Asked Questions (FAQ)

What is the current Tango Therapeutics share price?
The current share price of Tango Therapeutics is US$ 2,805
How many Tango Therapeutics shares are in issue?
Tango Therapeutics has 107.417.818 shares in issue
What is the market cap of Tango Therapeutics?
The market capitalisation of Tango Therapeutics is USD 314,2M
What is the 1 year trading range for Tango Therapeutics share price?
Tango Therapeutics has traded in the range of US$ 2,70 to US$ 13,005 during the past year
What is the PE ratio of Tango Therapeutics?
The price to earnings ratio of Tango Therapeutics is -3,04
What is the cash to sales ratio of Tango Therapeutics?
The cash to sales ratio of Tango Therapeutics is 8,47
What is the reporting currency for Tango Therapeutics?
Tango Therapeutics reports financial results in USD
What is the latest annual turnover for Tango Therapeutics?
The latest annual turnover of Tango Therapeutics is USD 36,53M
What is the latest annual profit for Tango Therapeutics?
The latest annual profit of Tango Therapeutics is USD -101,74M
What is the registered address of Tango Therapeutics?
The registered address for Tango Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Tango Therapeutics website address?
The website address for Tango Therapeutics is www.tangotx.com
Which industry sector does Tango Therapeutics operate in?
Tango Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PHIOPhio Pharmaceuticals Corporation
US$ 5,0499
(198,81%)
56,15M
SLRXSalarius Pharmaceuticals Inc
US$ 4,0499
(158,78%)
29,78M
ATPCAgape ATP Corporation
US$ 2,18
(73,02%)
40,79M
SAGESage Therapeutics Inc
US$ 7,55
(36,04%)
1,86M
ITCIIntra Cellular Therapies Inc
US$ 127,77
(34,68%)
5,2M
SVMHSRIVARU Holding Ltd
US$ 0,0384
(-37,86%)
61,08M
CMTLComtech Telecommunications Corporation
US$ 2,80
(-32,20%)
292,94k
ESTAEstablishment Labs Holdings Inc
US$ 31,47
(-31,27%)
307,23k
SMXSMX Security Matters Public Company
US$ 0,288
(-28,22%)
6,31M
NAYANAYA Biosciences Inc
US$ 0,60
(-26,24%)
160,12k
GCTKGlucoTrack Inc
US$ 0,14585
(24,66%)
287,19M
SVMHSRIVARU Holding Ltd
US$ 0,0384
(-37,86%)
61,08M
PHIOPhio Pharmaceuticals Corporation
US$ 5,0499
(198,81%)
56,15M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0681
(-22,70%)
52,96M
RIMEAlgorhythm Holdings Inc
US$ 0,12
(-10,98%)
45,71M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
TNGX
Tango Therapeutics
BIT
1TMO
Thermo Fisher Scientific
COIN
LEAFFFUSD
LeafCoin
BIT
30IA
ETF
BIT
P228M7
NLBNPIT228M7 20991231 18...
BIT
EUE
Exchange Traded
AQSE
IOF.GB
Iofina
AQSE
CAR.GB
Carclo
BIT
UC0SAY
Unicredit Bank
BIT
DAX3L
SG ETC DAX +3x Daily Lev...
BIT
XPXJ
Xtrackers MSCI Pacific e...
BIT
AIAI
L&G Artificial Intellige...
BIT
GBHY
Invesco Global High Yiel...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten